Enhancement of nortriptyline penetration through human epidermis: Influence of chemical enhancers and iontophoresis

Journal of Pharmacy and Pharmacology

Volumn 60, Issue 4, 2008, Pages 415-420

  Merino, Virginia ^a   Micó Albiñana, Teresa ^a   Nácher, Amparo ^a   Díez Sales, Octavio ^a   Herráez, Marina ^a   Merino Sanjuán, Matilde ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LAUROCAPRAM; LAURYL ALCOHOL; LIMONENE; MYRISTIC ACID ISOPROPYL ESTER; NORTRIPTYLINE; PROPYLENE GLYCOL; SORBITAN LAURATE;

ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG PENETRATION; EPIDERMIS; HUMAN; HUMAN TISSUE; IONTOPHORESIS; LIPOPHILICITY; SKIN ABSORPTION; SKIN PERMEABILITY; SMOKING CESSATION;

ADMINISTRATION, CUTANEOUS; ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; AZEPINES; CYCLOHEXENES; DIFFUSION; DODECANOL; EPIDERMIS; FEMALE; HEPES; HEXOSES; HUMANS; IONTOPHORESIS; MIDDLE AGED; MYRISTATES; NORTRIPTYLINE; PERMEABILITY; SKIN ABSORPTION; TERPENES; VEHICLES;

EID: 41849092673     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.60.4.0002     Document Type: Article

References (29)

1. Bailey, D. N. (1990) Percutaneous absorption of tricyclic antidepressants amitriptyline, nortriptyline, imipramine and desipramine. J. Anal. Toxicol. 14: 217-218
2. Barry, B. W. (2001) Novel mechanisms and devices to enable successful transdermal drug delivery. Eur. J. Pharm. Sci. 14: 101-114
3. Bauerova, K., Matusova, D., Kassai, Z. (2001) Chemical enhancers for transdermal drug transport. Eur. J. Drug Metab. Pharmacokinet. 26: 85-94
4. Bouwstra, J. A., Peschier, L. J. C., Brusse, J., Bodde, H. E. (1989) Effect of N-alkyl-azocycloheptan-2-ones including azone on the thermal behaviour of human stratum corneum. Int. J. Pharm. 52: 47-54
5. Delgado-Charro, M. B., Guy, R. H. (1995) Iontophoretic delivery of nafarelin across the skin. Int. J. Pharm. 117: 165-172
6. Delgado-Charro, M. B., Rodríguez-Bayón, A. M., Guy, R. H. (1995) Iontophoresis of nafarelin: effects of current density and concentration on electrotransport in vitro. J. Control. Release 35: 35-40
7. Finnin, B. C., Morgan, T. M. (1999) Transdermal penetration enhancers: applications, limitations, and potential. J. Pharm. Sci. 88: 955-958
8. Ghahramani, P., Lennard, M. S. (1996) Quantitative analysis of amitriptyline and nortriptyline in human plasma and liver microsomal preparations by high-performance liquid chromatography. J. Chromatogr. B Biomed. Appl. 685: 307-313
9. Glikfeld, P., Cullander, C., Hinz, R. S., Guy, R. H. (1988) A new system for in vitro studies of iontophoresis. Pharm. Res. 5: 443-446
10. Guo, H., Liu, Z., Li, J., Nie, S., Pan, W. (2006) Effects of isopropyl palmitate on the skin permeation of drugs. Biol. Pharm. Bull. 29: 2324-2326
11. Hanafy, A., Langguth, P., Spahn-Langguth, H. (2001) Pretreatment with potent P-glycoprotein ligands may increase intestinal secretion in rats. Eur. J. Pharm. Sci. 12: 405-415
12. Kalia, Y. N., Naik, A., Garrison, J., Guy, R. H. (2004) Iontophoretic drug delivery. Adv. Drug. Del. Rev. 56: 619-658
13. Kanikkannan, N., Kandimalla, K., Lamba, S. S., Singh, M. (2000) Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr. Med. Chem. 7: 593-608
14. Kvist, E. E., Al-Shurbaji, A., Dahl, M. L., Nordin, C., Alvan, G., Stahle, L. (2001) Quantitative pharmacogenetics of nortriptyline: A novel approach. Clin. Pharmacokinet. 40: 869-877
15. Lopez, A., Llinares, F., Cortell, C., Herráez, M., (2000) Comparative enhancer effect of Span20 with Tween20 and Azone on the in vitro percutaneous penetration of compounds with different lipophilicities. Int. J. Pharm. 202: 133-140
16. Marro, D., Kalia, Y. N., Delgado-Charro, M. B., Guy, R. H. (2001) Contributions of electromigration and electroosmosis to iontophoretic drug delivery. Pharm. Res. 18: 1701-1708
17. McEvoy, G. K. (2000) (ed.) Nortriptyline hydrochloride. In: AHFS (American Hospital Formulary Service), pp 2036
18. Merlé, Y., Mentré, F. (1999) Optimal sampling times for Bayesian estimation of the pharmacokinetic parameters of nortriptyline during therapeutic drug monitoring. J. Pharmacokinet. Biopharm. 27: 85-101
19. Phipps, J. B., Padmanabhan, R. V., Lattin, G. A. (1989) Iontophoretic delivery of model inorganic and drug ions. J. Pharm. Sci. 78: 365-369
20. Pikal, M. J., Shah, S. (1990) Transport mechanisms in iontophoresis II. Electroosmotic flow and transference number measurements for hairless mouse skin. Pharm. Res. 7: 213-221
21. PubChem, http://pubchem.ncbi.nlm.nih.gov/search/
22. Reynolds, J. E. F. (1993) Martindale, The extra pharmacopoeia. 30th edn, The Pharmaceutical Press, London, p. 266
23. Ribaud, C., Garson, J. C., Doucet, J., Leveque, J. L. (1994) Organization of stratum corneum lipids in relation to permeability: influence of sodium lauryl sulfate and preheating. Pharm. Res. 11: 1414-1418
24. Rodríguez Bayón, A. M., Guy, R. H. (1996) Iontophoresis of nafarelin across human skin in vitro. Pharm. Res. 13: 798-800
25. Ruiz-Angel, M. J., Carda-Broch, S., Simo-Alfonso, E. F., Garcia-Alvarez-Coque, M. C. (2003) Optimised procedures for the reversed-phase liquid chromatographic analysis of formulations containing tricyclic antidepressants. J. Pharm. Biomed. Anal. 32: 71-84
26. Scheuplein, R. J. (1967) Mechanisms of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration. J. Invest. Dermatol. 48: 79-88
27. Shah, V. P., Midha, K. K., Dighe, S., McGilveray, I. J., Skelly, J. P., Yacobi, A., Layloff, T., Viswanathan, C. T, Cook, C. E., McDowall, R. D., Pittman, K. A., Spector, S. (1992) Analytical methods validation: bioavailability, bioequivalence, and pharmacokinetic studies. J. Pharm. Sci. 81: 309-312
28. Wagena, E. J., Knipschild, P., Zeegers, M. P. (2005) Should nortriptyline be used as a first-line aid to help smokers quit? Results from a systematic review and meta-analysis. Addiction 100: 317-326
29. Williams, A. C., Barry, B. W. (2004) Penetration enhancers. Adv. Drug Deliv. Rev. 56: 603-618